12936 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2324)
  9. Epidemiology and Biostatistics (1997)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterization of genomic diversity in high grade serous ovarian and triple negative breast cancer at single cell resolution
    Meeting Abstract

    Williams, M. J.; Funnell, T.; O'Flanagan, C. H.; McPherson, A.; Aparicio, S.; Shah, S. P.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The role of EGFR in resistance to tucatinib and its therapeutic implications
    Meeting Abstract

    Veeraraghavan, J.; Liao, F. T.; Gordon, T.; Selenica, P.; Nanda, S.; Qin, L.; Zhu, Y.; Patel, J. A.; Gazzo, A.; Stossi, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Exportin 1 inhibition as a therapeutic strategy for small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chromosomal instability as a mediator of anti-tumor immunity in pancreatic cancer
    Meeting Abstract

    Bronder, D.; Sriram, R. K.; Bakhoum, S. F.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Unraveling the mechanisms underlying micronuclear rupture, a seminal event in cancer progression
    Meeting Abstract

    Di Bona, M.; Agustinus, A.; Chen, Y.; Scipioni, L.; Bronder, D.; Bakhoum, S. F.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • APR-246 enhances tumor immunogenicity even in the absence of p53
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Liu, C.; Budhu, S.; George, M. M.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save